Keratoprostheses 510(k)s
This article was originally published in The Gray Sheet
Executive Summary
Clinical investigations of permanent keratoprostheses (21 CFR 886.3400) require a minimum of 20 patients with follow-up of at least one year, FDA says in a guidance document posted on the agency's website April 26. Any "extraordinary claims will require the calculation of an appropriate sample size sufficient to support the specific claim," according to FDA, which notes that clinical data are not needed for temporary keratoprostheses
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.